Sakar Healthcare Signs 40th Agreement with Zydus Lifesciences

Sakar Healthcare signed its 40th global agreement with Zydus Lifesciences to supply oncology products in GCC and emerging markets.
Company filed 23 Marketing Authorizations in EU and submitted 33 site variations across European markets including UK and Germany.
Sakar developed 21 APIs in-house with 16 having Written Confirmation and 2 CEP approvals secured, enhancing backward integration.
Managing Director highlighted progress in regulatory approvals and API pipeline positioning company for scalable growth and market expansion.